1. Home
  2. ARE vs RGEN Comparison

ARE vs RGEN Comparison

Compare ARE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

HOLD

Current Price

$59.63

Market Cap

8.8B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$161.91

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARE
RGEN
Founded
1994
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ARE
RGEN
Price
$59.63
$161.91
Analyst Decision
Hold
Buy
Analyst Count
11
11
Target Price
$58.33
$177.18
AVG Volume (30 Days)
2.3M
577.2K
Earning Date
01-26-2026
02-19-2026
Dividend Yield
7.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$3,058,395,000.00
$707,890,000.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$12.44
P/E Ratio
N/A
$5,257.58
Revenue Growth
N/A
11.74
52 Week Low
$44.10
$102.97
52 Week High
$105.14
$182.52

Technical Indicators

Market Signals
Indicator
ARE
RGEN
Relative Strength Index (RSI) 75.04 45.60
Support Level $56.07 $157.29
Resistance Level $58.22 $174.87
Average True Range (ATR) 1.66 7.07
MACD 0.79 -0.52
Stochastic Oscillator 99.86 23.05

Price Performance

Historical Comparison
ARE
RGEN

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: